VERAXA Biotech GmbH

Industry sector:Biotechnology
Products, services:ADC Development and Antibody Screening
Locations:69124 Heidelberg, Carl-Friedrich-Gauß-Ring 5
Date of foundation:2021
Number of employees:32
The company:VERAXA is an early-stage biotechnology company with game changing functional antibody discovery and conjugation technology yielding ADCs at scale for the treatment of Cancer. Its proprietary high throughput droplet-based microfluidic platform can screen entire immune repertoires with millions of antibody secreting cells for antibody binding, functionality, and internalization on a single-cell level. VERAXA’s unique conjugation technology utilizes fastest bioorthogonal click chemistry coupled with genetic code expansion to precisely and efficiently conjugate payloads/oligos/ radionuclide at freely selectable antibody sites.
Area of expertise:Biosciences, Chemistry, Mathematics, Biochemistry, Physics,
Computer Sciences, Biotechnology
Desired qualifications:PostDoc, PhD, master, bachelor, technicians
Career opportunities:direct entry
Trainee program (positions/year):No